
When patients fall outside pivotal clinical trial criteria, retina specialists factor in real-world judgment to guide treatment.

When patients fall outside pivotal clinical trial criteria, retina specialists factor in real-world judgment to guide treatment.

Three cases illustrate treatment switches and extension intervals across retinal vein occlusion, age-related macular degeneration, and diabetic retinopathy.

Two cases highlight the diagnostic challenges of Demodex blepharitis and underscore the unmet need for approved targeted therapies in the United Kingdom.